Overexpression of HBxAg in hepatocellular carcinoma and its relationship with Fas/FasL system

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 12

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

390

HTML

3006

Figures (1-3)

179

Tables (1-3)

189

Sum=3764

Dec 15, 2003 (publication date) through Nov 23, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Dec 15, 2003; 9(12): 2671-2675
Published online Dec 15, 2003. doi: 10.3748/wjg.v9.i12.2671

Table 2 Serum levels of sFas and sFasL in patients with HCC and Cirrhosis (μg·L^-1)

^aP < 0.01, vs control.

Citation: Wang XZ, Chen XC, Chen YX, Zhang LJ, Li D, Chen FL, Chen ZX, Chen HY, Tao QM. Overexpression of HBxAg in hepatocellular carcinoma and its relationship with Fas/FasL system. World J Gastroenterol 2003; 9(12): 2671-2675
URL: https://www.wjgnet.com/1007-9327/full/v9/i12/2671.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i12.2671